Literature DB >> 27630214

Regulation of FcRγ function by site-specific serine phosphorylation.

Spandan Shah1, Andrew W Gibson2, Chuanyi Ji1, Eric Darrington1, James Mobley3, Kyoko Kojima3, Jeffrey C Edberg1, Robert P Kimberly1.   

Abstract

The common FcRγ, an immunoreceptor tyrosine-based activation motif (ITAM)- containing adaptor protein, associates with multiple leukocyte receptor complexes and mediates signal transduction through the ITAM in the cytoplasmic domain. The presence of multiple serine and threonine residues within this motif suggests the potential for serine/threonine phosphorylation in modulating signaling events. Single-site mutational analysis of these residues in RBL-2H3 cells indicates that each may contribute to net FcRγ-mediated signaling, and mass spectrometry of WT human FcRγ from receptor-stimulated cells shows consistent preferential phosphorylation of the serine residue at position 51. Immunoblot analysis, mass spectrometry, and mutational analyses showed that phosphorylation of serine 51 in the 7-residue spacer between the 2 YxxL sequences regulates FcRγ signaling by inhibiting tyrosine phosphorylation at the membrane proximal Y47 position of the ITAM, but not phosphorylation at position Y58. This inhibition results in reduced Syk recruitment and activation. With in vitro kinase assays, PKC-δ and PKA show preferential phosphorylation of S51. Serine/threonine phosphorylation of the FcRγ ITAM, which functions as an integrator of multiple signaling elements, may explain in part the contribution of variants in PKC-δ and other PKC isoforms to some autoimmune phenotypes. © Society for Leukocyte Biology.

Entities:  

Keywords:  ITAM; Syk recruitment; adaptor protein; receptor inhibition; signaling protein

Mesh:

Substances:

Year:  2016        PMID: 27630214      PMCID: PMC5235907          DOI: 10.1189/jlb.2AB0516-228R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.

Authors:  Andrew W Gibson; Xinrui Li; Jianming Wu; Julie G Baskin; Chander Raman; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2011-10-14       Impact factor: 4.962

2.  Requirement of the Fc receptor common gamma-chain for gamma delta T cell-mediated promotion of murine experimental autoimmune encephalomyelitis.

Authors:  Alexander J Szalai; Xianzhen Hu; Chander Raman; Scott R Barnum
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

3.  Syk-independent tyrosine phosphorylation and association of the protein tyrosine phosphatases SHP-1 and SHP-2 with the high affinity IgE receptor.

Authors:  T Kimura; J Zhang; K Sagawa; K Sakaguchi; E Appella; R P Siraganian
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

4.  Phosphorylation of the gamma chain of the high affinity receptor for immunoglobulin E by receptor-associated protein kinase C-delta.

Authors:  P Germano; J Gomez; M G Kazanietz; P M Blumberg; J Rivera
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

5.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Authors:  W L Hazenbos; J E Gessner; F M Hofhuis; H Kuipers; D Meyer; I A Heijnen; R E Schmidt; M Sandor; P J Capel; M Daëron; J G van de Winkel; J S Verbeek
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

6.  Requirement for a negative charge at threonine 60 of the FcRgamma for complete activation of Syk.

Authors:  P G Swann; S Odom; Y J Zhou; Z Szallasi; P M Blumberg; P Draber; J Rivera
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

7.  Deletion of the Fc receptors gamma chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet.

Authors:  Katsuhiko Sumiyoshi; Hiroshi Mokuno; Takafumi Iesaki; Kazunori Shimada; Tetsuro Miyazaki; Atsumi Kume; Takashi Kiyanagi; Kenichi Kuremoto; Yoshiro Watanabe; Nobuhiro Tada; Hiroyuki Daida
Journal:  Cardiovasc Res       Date:  2008-08-11       Impact factor: 10.787

8.  Protein tyrosine phosphatase inhibitors block myeloid signal transduction through the Fc gamma RI receptor.

Authors:  D L Durden; H Rosen; B R Michel; J A Cooper
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

9.  Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association.

Authors:  H C Morton; I E van den Herik-Oudijk; P Vossebeld; A Snijders; A J Verhoeven; P J Capel; J G van de Winkel
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo.

Authors:  M J van Vugt; I A Heijnen; P J Capel; S Y Park; C Ra; T Saito; J S Verbeek; J G van de Winkel
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  3 in total

1.  Dectin-1 intracellular domain determines species-specific ligand spectrum by modulating receptor sensitivity.

Authors:  Tomotsugu Takano; Chihiro Motozono; Takashi Imai; Koh-Hei Sonoda; Yoichi Nakanishi; Sho Yamasaki
Journal:  J Biol Chem       Date:  2017-08-28       Impact factor: 5.157

2.  Identification of FCER1G related to Activated Memory CD4+ T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma.

Authors:  Xiaoyu Xiang; Li-Min Gao; Yuehua Zhang; Yuan Tang; Sha Zhao; Weiping Liu; Yunxia Ye; Wenyan Zhang
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

3.  Identification of diagnostic markers and immune cell infiltration characteristics in antineutrophil cytoplasmic antibody-associated vasculitis by weighted gene co-expression network analysis.

Authors:  Mengdi Xia; Fen Zhao; Yongji Zhang; Zhihuang Zheng; Yun Zhou; Tong Liu
Journal:  Eur J Med Res       Date:  2022-03-05       Impact factor: 2.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.